Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_assertion type Assertion NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_head.
- NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_assertion wasGeneratedBy ECO_0000203 NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_provenance.
- NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_assertion wasDerivedFrom befree-2016 NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_provenance.
- NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_assertion SIO_000772 21246292 NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_provenance.
- NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_assertion evidence source_evidence_literature NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_provenance.
- NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_assertion description "[The identification of BRCA1/BRCA2 mutations in women with ovarian cancer allows for accurate predictive genetic testing of their at-risk relatives, who can then avail themselves of early detection and risk reduction strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866242.RAAUyxeLtcS4cpnEPGhn4GH_4-MOzxWuHQb3PzcNo3YgM130_provenance.